About Us

”DCompany Profile

”DMilestone

”DOur Vision

Milestone

Home > About Us > Milestone


”@

”DCorporation of the company.


”@

”DStart-up of the R&D laboratory with dedicated focus on Prostaglandin (PG) APIs.


”@

”DBuild-up of Pingdung Plant with successful commercial production of first PG, Alprostadil.


”@

”D

cGMP compliance by governmental audit.

”D

Start-up of Wulin Plant and build-up of the dedicated commercial production of Latanoprost in cGMP compliance.


”@

”D

Filing of two process patents for commercial feasible and proprietary synthesis of PGF2£\ molecules including Latanoprost, Bimatoprost, and Travoprost with major patent offices worldwide.

”D

Filing of first US DMF for Latanoprost.


”@

”D

Acquisition of a land designated for hundreds kg production of veterinary PGs and PG intermediates at ChungLi Industrial Park.

”D

First successful US FDA Inspection.


”@

”D

Expansion of Wulin plant to include additional 2 independent and dedicated production modules.

”D

Acquisition of a plant located at Youth Industrial Park for further expansion of production capacities as well as operation activities.


”@

”D

Filing US DMF for Bimatoprost.

”D

Expansion of Youth plant to include additional 5-6 independent and dedicated production workshops.

”D

Completion of construction of Chungli plant which is designed capable of handling production of PG intermediates or APIs up to hundreds kgs.

”@

CHIROGATE INTERNATIONAL INC.TEL: 886-3-4963808FAX: 886-3-4963800E-mail:sales@chirogate.com